BHC — Bausch Health Companies Share News
0.000.00%
Last trade - 00:00- $2.37bn
- $22.29bn
- $10.27bn
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: Bausch Health Companies -Co And Yun Expand Strategic Collaboration In Mexico And EMEA Markets
Canada Stocks: Toronto stocks near record high as investors weigh earnings, US PPI data
Bausch Health Companies Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Bausch Health Q2 results beat estimates; raises 2026 outlook
Bausch Health Companies Inc expected to post earnings of $1.04 a share - Earnings Preview
Canada Stocks: Financial stocks drag TSX lower; Middle East jitters linger
Brief: Michael Goettler Resigns From Bausch Health's Board Of Directors
Brief: Michael Goettler Resigns From Bausch Health's Board Of Directors
Canada Stocks: TSX heads for monthly gain as mining stocks rise, oil retreats
Canada's Bausch Health Q1 revenue rises
Canada's Bausch Health beats Q1 adjusted EPS estimates
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case
Canada Stocks: TSX subdued as healthcare, financials drag; energy gains
Canada's Bausch Health Q4 revenue rises 9%, reports net loss
Bausch Health falls after brain dysfunction treatment fails late-stage trials
Bausch Health's brain dysfunction treatment fails late-stage trials (updated)
Bausch Health's brain dysfunction treatment fails late-stage trial